DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Prospective Randomized Study on Vanguard Cruciate Retaining Versus Vanguard High Flex Posterior Stabilized Total Knee System in the Early Range of Motion

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Total Knee Arthroplasty

Intervention: Vanguard PS Knee (Device); Vanguard CR Knee (Device)

Phase: N/A

Status: Recruiting

Sponsored by: Biomet, Inc.

Official(s) and/or principal investigator(s):
David Martin, MD, Principal Investigator, Affiliation: St. Catharines Hospital

Overall contact:
David Martin, MD, Phone: (905) 684-7271

Summary

Main Objectives are: Test Difference in terms of early ROM between Vanguard FB CR and Vanguard FB PS. Knees; Demonstrate the comparable ROM of high flex PS to CR.

Clinical Details

Official title: A Prospective Randomized Study on Vanguard Cruciate Retaining Versus Vanguard High Flex Posterior Stabilized Total Knee System in the Early Range of Motion

Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Knee Society Score

Secondary outcome:

WOMAC

Oxford Knee

Complication

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Patients need total knee replacement

Locations and Contacts

David Martin, MD, Phone: (905) 684-7271

St. Catharines Hospital, Ontario, Canada; Recruiting
David Martin, MD
Additional Information

Starting date: June 2007
Ending date: June 2011
Last updated: October 8, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009